CN106316975A - 酰胺类化合物及其作为tgr5激动剂的应用 - Google Patents
酰胺类化合物及其作为tgr5激动剂的应用 Download PDFInfo
- Publication number
- CN106316975A CN106316975A CN201510329936.3A CN201510329936A CN106316975A CN 106316975 A CN106316975 A CN 106316975A CN 201510329936 A CN201510329936 A CN 201510329936A CN 106316975 A CN106316975 A CN 106316975A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- amino
- alkoxyl
- hydroxyl
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*1(CC1)c(cc1)ccc1N Chemical compound C*1(CC1)c(cc1)ccc1N 0.000 description 6
- AXLHSKUPSLOJLO-UHFFFAOYSA-N C=C(c1ccc[n]1-c1ccccc1I)O Chemical compound C=C(c1ccc[n]1-c1ccccc1I)O AXLHSKUPSLOJLO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510329936.3A CN106316975A (zh) | 2015-06-15 | 2015-06-15 | 酰胺类化合物及其作为tgr5激动剂的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510329936.3A CN106316975A (zh) | 2015-06-15 | 2015-06-15 | 酰胺类化合物及其作为tgr5激动剂的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106316975A true CN106316975A (zh) | 2017-01-11 |
Family
ID=57733219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510329936.3A Pending CN106316975A (zh) | 2015-06-15 | 2015-06-15 | 酰胺类化合物及其作为tgr5激动剂的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106316975A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108727377A (zh) * | 2017-04-14 | 2018-11-02 | 四川大学 | 3-氰基吡唑并[1,5-a]嘧啶衍生物及其制备方法和用途 |
CN112010774A (zh) * | 2019-05-28 | 2020-12-01 | 上海美悦生物科技发展有限公司 | FXIa凝血因子抑制剂、其药物组合物和用途 |
CN113004207A (zh) * | 2021-03-05 | 2021-06-22 | 中国医科大学 | Plk4小分子抑制剂的化合物及其应用 |
WO2022036506A1 (zh) * | 2020-08-17 | 2022-02-24 | 天津睿创康泰生物技术有限公司 | Sglt-2抑制剂与血管紧张素受体阻滞剂的组合物及用途 |
CN116813691A (zh) * | 2018-10-29 | 2023-09-29 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104220429A (zh) * | 2011-12-21 | 2014-12-17 | 阿德利克斯公司 | 非全身性tgr5激动剂 |
-
2015
- 2015-06-15 CN CN201510329936.3A patent/CN106316975A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104220429A (zh) * | 2011-12-21 | 2014-12-17 | 阿德利克斯公司 | 非全身性tgr5激动剂 |
Non-Patent Citations (3)
Title |
---|
-: "RN 1329581-04-5,RN 1329550-35-7,RN 1329332-65-1,RN 1327049-62-6,RN 1177769-11-7,RN 933257-38-6,RN 932301-26-3,RN 878691-76-0,RN 1064428-72-3,RN 1064427-69-5,RN811412-81-4", 《STN REGISTRY》 * |
BRIAN W.BUDZIK ET AL.: "Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists", 《BIOORG.MED.CHEM.LETT.》 * |
CHEN ZHOU ET AL.: "Identification of new non-steroidal TGR5 agonists using virtual screening with combined pharmacophore models", 《MED CHEM RES》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108727377A (zh) * | 2017-04-14 | 2018-11-02 | 四川大学 | 3-氰基吡唑并[1,5-a]嘧啶衍生物及其制备方法和用途 |
CN116813691A (zh) * | 2018-10-29 | 2023-09-29 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
CN116813691B (zh) * | 2018-10-29 | 2024-04-12 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
CN112010774A (zh) * | 2019-05-28 | 2020-12-01 | 上海美悦生物科技发展有限公司 | FXIa凝血因子抑制剂、其药物组合物和用途 |
CN112010774B (zh) * | 2019-05-28 | 2024-03-08 | 上海美悦生物科技发展有限公司 | FXIa凝血因子抑制剂、其药物组合物和用途 |
WO2022036506A1 (zh) * | 2020-08-17 | 2022-02-24 | 天津睿创康泰生物技术有限公司 | Sglt-2抑制剂与血管紧张素受体阻滞剂的组合物及用途 |
CN113004207A (zh) * | 2021-03-05 | 2021-06-22 | 中国医科大学 | Plk4小分子抑制剂的化合物及其应用 |
CN113004207B (zh) * | 2021-03-05 | 2023-10-17 | 中国医科大学 | Plk4小分子抑制剂的化合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106316975A (zh) | 酰胺类化合物及其作为tgr5激动剂的应用 | |
US8575166B2 (en) | Phthalazine-containing antidiabetic compounds | |
CN106317027A (zh) | 杂芳基酰胺类衍生物及其作为tgr5激动剂的应用 | |
US7053094B2 (en) | Compositions and methods for treating heart failure | |
CN105518008B (zh) | 氨基吡喃环衍生物及其组合物和应用 | |
NZ550511A (en) | 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors | |
CN102898400B (zh) | Gpr119激动剂及其应用 | |
CN104059042B (zh) | C-三芳基葡萄糖苷类sglt-2抑制剂 | |
WO2023049518A1 (en) | Benzimidazole carboxylic acids as glp-1r agonists | |
US20060258637A1 (en) | Fused polycyclic compounds | |
EP1124821A1 (en) | Compounds | |
CN108299420B (zh) | 作为选择性雌激素受体下调剂的五环类化合物及其应用 | |
WO2017095722A1 (en) | Aryl acylsulfonamides as blt1 antagonists | |
CN106458966A (zh) | 作为磷脂酰肌醇3‑激酶抑制剂的吡嗪衍生物 | |
CN104797553B (zh) | 3‑氨基环戊烷甲酰胺衍生物 | |
EP3383389B1 (en) | Aryl acylsulfonamides as blt1 antagonists | |
CN102993197A (zh) | 托品酮衍生物及其制备方法和应用 | |
CN103601674B (zh) | 一种抑制二肽激肽酶的化合物及制备方法和用途 | |
CN106866678A (zh) | 吡咯并嘧啶酮类化合物及其制备方法和应用 | |
CN115246816B (zh) | 一种双靶点阿格列汀衍生物 | |
CN110256420B (zh) | 四氢吡啶并嘧啶衍生物及其制备方法和用途 | |
CN107686463A (zh) | 一类查尔酮芳氧乙酰胺化合物、制备方法及其应用 | |
CN106046101A (zh) | 一种糖原磷酸化酶抑制剂及其制备方法和应用 | |
JP2004010523A (ja) | 縮合多環式化合物およびその医薬用途 | |
WO2023076237A1 (en) | Compounds as glp-1r agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180524 Address after: No. 2518, Tianchen Road, Ji'nan high tech Zone, Shandong, Shandong Applicant after: Shandong Xuanzhu Medical Technology Co., Ltd. Applicant after: Beijing Sihuan Pharmaceutical Co., Ltd. Address before: 250101 2518 Tianchen Road, hi tech Development Zone, Ji'nan, Shandong Applicant before: Shandong Xuanzhu Medical Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181126 Address after: 101113 No. 13 Guangyuan West Street, Zhangjiawan Town, Tongzhou District, Beijing Applicant after: Beijing Sihuan Pharmaceutical Co., Ltd. Address before: No. 2518, Tianchen Road, Ji'nan high tech Zone, Shandong, Shandong Applicant before: Shandong Xuanzhu Medical Technology Co., Ltd. Applicant before: Beijing Sihuan Pharmaceutical Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170111 |
|
WD01 | Invention patent application deemed withdrawn after publication |